DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the ARTEMIS MED SERVICE LTD (ARTEMISMED) share price today?

ARTEMIS MED SERVICE LTD (ARTEMISMED) is trading at ₹269.35 on the NSE, down 2.20% on the day. Source: DocStoX.

What is the PE ratio of ARTEMIS MED SERVICE LTD?

ARTEMIS MED SERVICE LTD has a price-to-earnings (PE) ratio of 44.4 in the Healthcare sector.

What is the market capitalisation of ARTEMIS MED SERVICE LTD?

ARTEMIS MED SERVICE LTD has a market capitalisation of approximately ₹4,249 crore.

ARTEMIS MED SERVICE LTD

ARTEMISMED·NSE·Healthcare

₹269.35▼ -6.05 (-2.20%)

Healthcare · Hospital

A steady, established business

Day₹267.35

₹277.10

52W₹203

₹29870%

Open

₹274.35

High

₹277.10

Low

₹267.35

Prev Close

₹275.40

Volume

1.06L

VWAP

₹271.82

Snapshot

Key fundamentals

Market Cap

₹4,249 Cr

P/E Ratio

44.37Expensive

P/B Ratio

4.90

EPS

₹6.07

Book Value

₹54.69

ROE

11.03%Average

ROCE

15.00%Decent

Dividend Yield

0.17%

Debt / Equity

0.28Low

Face Value

₹1.00

52W High

₹297.50

52W Low

₹203.35

Sector

Healthcare

Industry

Hospital

Avoid

None moatHigh uncertainty

Fair value estimate

₹61

▼ 77.4%downside

Trading at ₹269 — 77% above our estimate

BearFair valueBull

₹52₹61₹86

/100

Business quality — Watch the fundamentals

Growth 25Profitability 35Efficiency 18Valuation 50

Plain English

Our view

A steady, established business
Low debt relative to equity
Fundamental red flags (Piotroski 2/9)

Strengths

Low debt relative to equity
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

11% ROE fading to 12% over ~3 yrs, on ₹55 book

₹54

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹86

Analyst target

No analyst coverage

—

Blended fair value₹61

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

44.4Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

11.0%Average

Above 15% is considered healthy for Indian equities

ROCE

15.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.28Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹4,249 Cr

P/B

4.90

EPS

₹6.07

Div Yield

0.17%

What changed

Recent changes

Domestic institutions-0.5% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 44.4×

Growth

Steady

+15% rev CAGR

Profitability

Modest

11.0% ROE

Financial health

Rock solid

D/E 0.28

Momentum

N/A

No technicals

Today

Trading activity

Delivery %51.3%

Turnover₹288.10L Cr

Trades3,113

VWAP₹271.82

Face value₹1.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+14.8%

+21.9%

10Y

+10.4%

Profit

+37.3%

+71.4%

10Y

+16.8%

EPS

—

10Y

—

Profile

Pros

Company has delivered good profit growth of 75.6% CAGR over last 5 years

Watch-outs

Cons

Stock is trading at 4.67 times its book value
Company has a low return on equity of 12.1% over last 3 years.
Promoter holding has decreased over last 3 years: -10.5%

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Domestic institutions reduced 0.49 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

58%

Promoter

Promoters

58.4%0.00

Public

20.8%+0.39

FII / FPI

12.3%+0.09

DII

2.4%-0.49

Others

6.2%

Quarterly trend

Ownership over time

Q1 FY27

Promoter58.39%

FII12.28%

DII2.40%

Public20.76%

Others6.17%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. [1][2]